AT291283B - Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen - Google Patents

Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen

Info

Publication number
AT291283B
AT291283B AT330569A AT330569A AT291283B AT 291283 B AT291283 B AT 291283B AT 330569 A AT330569 A AT 330569A AT 330569 A AT330569 A AT 330569A AT 291283 B AT291283 B AT 291283B
Authority
AT
Austria
Prior art keywords
guanylhydrazones
salts
preparation
new
new guanylhydrazones
Prior art date
Application number
AT330569A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH499868A external-priority patent/CH495960A/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of AT291283B publication Critical patent/AT291283B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT330569A 1968-04-04 1969-04-03 Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen AT291283B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH499868A CH495960A (de) 1968-04-04 1968-04-04 Verfahren zur Herstellung von neuen Guanylhydrazonen
CH268269 1969-02-21

Publications (1)

Publication Number Publication Date
AT291283B true AT291283B (de) 1971-07-12

Family

ID=25691134

Family Applications (2)

Application Number Title Priority Date Filing Date
AT330569A AT291283B (de) 1968-04-04 1969-04-03 Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen
AT343970A AT297731B (de) 1968-04-04 1969-04-03 Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT343970A AT297731B (de) 1968-04-04 1969-04-03 Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen

Country Status (9)

Country Link
US (1) US3673241A (de)
AT (2) AT291283B (de)
BE (1) BE731015A (de)
DE (1) DE1914999A1 (de)
FR (1) FR2007382B1 (de)
GB (1) GB1241130A (de)
IE (1) IE33021B1 (de)
NL (1) NL6905258A (de)
SE (1) SE343574B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311432A (en) * 1971-01-07 1973-03-28 Ici Ltd Guanidine derivatives their preparation and antiviral compositions containing them
US3917678A (en) * 1972-01-25 1975-11-04 Squibb & Sons Inc Organic acid salts of 1-{8 0-{8 (3-dimethylaminopropyl)thio{9 phenyl{9 -3-methylurea
US4971986A (en) * 1988-03-25 1990-11-20 Ciba-Geigy Corporation Arylhydrazones useful as SAMDC inhibitors
US5238941A (en) * 1988-03-25 1993-08-24 Ciba-Geigy Corporation Arylhydrazones and pharmaceutical compositions thereof
AU7353300A (en) 1999-09-08 2001-04-10 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
WO2002059080A2 (en) 2001-01-25 2002-08-01 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
EP1757606B1 (de) * 2001-02-24 2009-05-06 Boehringer Ingelheim Pharma GmbH & Co. KG Xanthinderivate Verwendung als Arzneimittel sowie deren Verfahren zur deren Herstellung
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (de) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Zusammensetzungen von DPP-IV-Inhibitoren
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
AU2007247190A1 (en) * 2006-05-04 2007-11-15 Boehringer Ingelheim International Gmbh Polymorphs
CA2690410C (en) * 2007-06-12 2015-09-29 Provid Pharmaceuticals, Inc. Kinase inhibitors, compositions thereof, and methods of use therewith
JP5769966B2 (ja) * 2007-08-17 2015-08-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Fab関連疾患治療用プリン誘導体
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20200118243A (ko) 2008-08-06 2020-10-14 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
EA031225B1 (ru) * 2008-08-15 2018-12-28 Бёрингер Ингельхайм Интернациональ Гмбх Ингибиторы дпп-4 для заживления ран
KR20110067096A (ko) 2008-09-10 2011-06-21 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 및 관련 상태를 치료하기 위한 병용 요법
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
TWI508965B (zh) 2008-12-23 2015-11-21 Boehringer Ingelheim Int 有機化合物的鹽形式
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
EA034869B1 (ru) 2009-11-27 2020-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
NZ602921A (en) 2010-05-05 2016-01-29 Boehringer Ingelheim Int Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor
KR20220025926A (ko) 2010-06-24 2022-03-03 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
CA2841552C (en) 2011-07-15 2020-06-23 Boehringer Ingelheim International Gmbh Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
EP2849754B1 (de) 2012-05-14 2022-09-14 Boehringer Ingelheim International GmbH Linagliptin, ein xanthinderivat als dpp-4-hemmer, zur verwendung bei der behandlung von sirs und/oder sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
CN102924339B (zh) * 2012-11-23 2014-06-04 温州澳珀化工有限公司 一种制备米托胍腙的方法
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
EP3156394B1 (de) * 2014-06-10 2019-04-17 Mitsubishi Gas Chemical Company, Inc. Alkylidenaminoganidin und salz davon, modifikatorzusammensetzung, modifizierter kautschuk für reifen, kautschukzusammensetzung für reifen und reifen
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合
FR3112428A1 (fr) 2020-07-13 2022-01-14 Semco Smartech France Procédé de formation de contacts passivés pour cellules solaires IBC

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2584784A (en) * 1949-05-21 1952-02-05 Du Pont Salts of 1-salicylalaminoguanidine
FR1013816A (fr) * 1949-05-24 1952-08-05 Wander Ag Dr A Procédé pour la préparation de p-uréidobenzalthio-semicarbazones substituées
CH383948A (de) * 1959-07-22 1964-11-15 Ciba Geigy Verfahren zur Herstellung neuer Hydrazone
FR1332543A (fr) * 1962-01-09 1963-07-19 Ciba Geigy Nouvelles hydrazones et leur procédé de préparation

Also Published As

Publication number Publication date
FR2007382B1 (de) 1974-02-01
FR2007382A1 (de) 1970-01-09
DE1914999A1 (de) 1969-11-06
GB1241130A (en) 1971-07-28
NL6905258A (de) 1969-10-07
IE33021L (en) 1969-10-04
US3673241A (en) 1972-06-27
AT297731B (de) 1972-04-10
BE731015A (de) 1969-10-03
SE343574B (de) 1972-03-13
IE33021B1 (en) 1974-02-20

Similar Documents

Publication Publication Date Title
AT291283B (de) Verfahren zur Herstellung von neuen Guanylhydrazonen und ihren Salzen
AT299193B (de) Verfahren zur Herstellung von neuen Imidazolidinochinalinderivaten und ihren Salzen
AT285599B (de) Verfahren zur Herstellung von neuen trisubstituierten 2-Arylaminoimidazolinen und ihren Salzen
AT303024B (de) Verfahren zur Herstellung von neuen Aminophenyl-cycloamidinen und ihren Salzen
AT301523B (de) Verfahren zur Herstellung von neuen β-Amino-β-hydroxyphenylalkancarbonsäuren und ihren Salzen
AT287694B (de) Verfahren zur Herstellung von neuen Imidazolindinderivaten und ihren Salzen
AT292010B (de) Verfahren zur Herstellung von neuen Aminoguanidin-Derivaten und ihren Salzen
AT306741B (de) Verfahren zur Herstellung von neuen 3-Guanidinoalkyl-thiophenen und ihren Salzen
AT297727B (de) Verfahren zur Herstellung von neuen 3-Aryl-benzazinen und ihren Salzen
AT289808B (de) Verfahren zur Herstellung von neuen Tetrahydropyrimidinen und ihren Salzen
AT286278B (de) Verfahren zur Herstellung von neuen 2-Phenylimino-pyrrolidinen und ihren Salzen
AT288375B (de) Verfahren zur Herstellung von neuen Imidazolidinderivaten und ihren Salzen
AT287701B (de) Verfahren zur Herstellung von neuen Imidazolidinderivaten und ihren Salzen
AT280267B (de) Verfahren zur Herstellung von neuen 2-Iminomethyleniminen und ihren Salzen
AT311961B (de) Verfahren zur Herstellung von neuen 2-Arylimino-thiazolidinen und ihren Salzen
AT289807B (de) Verfahren zur Herstellung von neuen Benzoxazepinonen und ihren Salzen
AT283325B (de) Verfahren zur herstellung von neuen aminoketonen und ihren salzen
AT283323B (de) Verfahren zur herstellung von neuen aminoketonen und ihren salzen
AT291279B (de) Verfahren zur Herstellung von neuen Benzolsulfonylharnstoffderivaten und ihren Salzen
AT288372B (de) Verfahren zur Herstellung von neuen Imidazolidinderivaten und ihren Salzen
AT288377B (de) Verfahren zur Herstellung von neuen Imidazolidinderivaten und ihren Salzen
AT288376B (de) Verfahren zur Herstellung von neuen Imidazolidinderivaten und ihren Salzen
AT309700B (de) Verfahren zur Herstellung von neuen 2-Benzoylalbenzomorphanen und ihren Salzen
AT289793B (de) Verfahren zur Herstellung von neuen Tetrazolderivaten und ihren Salzen